![](/img/cover-not-exists.png)
LPA variants, risk of coronary disease, and estimated clinical benefit of lipoprotein(a) lowering therapies: A mendelian randomization analysis
Ference, B.A., Burgess, S., Staley, J.R., Freitag, D.F., Mason, A.M., Nielsen, S.F., Willeit, P., Young, R., Surendran, P., Karthikeyan, S., Bolton, T.R., Peters, J.E., Kamstrup, P.R., Tybjærg-Hansen,Volume:
275
Language:
english
Journal:
Atherosclerosis
DOI:
10.1016/j.atherosclerosis.2018.06.895
Date:
August, 2018
File:
PDF, 52 KB
english, 2018